Wireless Laboratory Equipment Temperature Monitoring System

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q133352

NAICS

334513 - Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Classification Code

6640

Additional Details
Set Aside

SBA

Place of Performance

Atlanta, Georgia, UNITED STATES

SourceSAM
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation (Procurement Identifier: 75F40126Q133352) for the acquisition of a Wireless Laboratory Equipment Temperature Monitoring System. This procurement seeks to enhance the FDA’s laboratory operations in Atlanta, Georgia, by implementing a robust, wireless solution for monitoring the temperature of laboratory equipment, thereby ensuring the integrity and reliability of critical research and testing environments. The scope of this procurement encompasses the provision, installation, and commissioning of a comprehensive wireless temperature monitoring system tailored for laboratory applications. The system is expected to deliver real-time monitoring, data logging, and alerting capabilities to safeguard sensitive materials and processes. The intended outcome is to maintain stringent environmental controls, support compliance with regulatory standards, and minimize the risk of temperature excursions that could compromise laboratory results or stored materials. Key requirements and objectives include the delivery of a system that is compatible with a variety of laboratory equipment, offers secure and continuous wireless data transmission, and integrates with existing FDA infrastructure. The solicitation addendum provides further clarity on the scope, security requirements, and includes responses to vendor questions as well as relevant floor plans, ensuring prospective contractors have a comprehensive understanding of the project environment and expectations. This opportunity is classified under NAICS Code 334513 (Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables), with Product Service Code 6640. The procurement is set aside for Small Business Administration (SBA) eligible entities, emphasizing the FDA’s commitment to supporting small business participation in federal contracting. The place of performance is specified as Atlanta, Georgia, United States. The contracting activity is managed by the FDA Office of Acquisition and Grant Services, a federal office within the Food and Drug Administration. Interested parties are encouraged to direct inquiries to the primary contact, Howard Nesmith, via email at [email protected] or by phone at 301-796-2138. The solicitation remains active, with the response due date extended to April 15, 2026, at 1:00 PM CST. All relevant documentation, including the combined synopsis/solicitation and addendum, is available through the official SAM.gov opportunity listing (Opportunity ID: 7965da4696a2441f90d11d69e98e5377). Contractors evaluating this opportunity should note the emphasis on technical capability, security compliance, and experience with laboratory monitoring systems. The requirements and performance expectations outlined in the solicitation are anticipated to remain consistent throughout the contract lifecycle, ensuring a stable framework for project execution and ongoing support.